4//SEC Filing
AMAG PHARMACEUTICALS INC. 4
Accession 0001179110-16-033386
CIK 0000792977operating
Filed
Dec 21, 7:00 PM ET
Accepted
Dec 22, 5:06 PM ET
Size
9.5 KB
Accession
0001179110-16-033386
Insider Transaction Report
Form 4
KELLEY BRIAN P
Director
Transactions
- Award
Stock Option (Right to Buy)
2016-12-20+2,739→ 2,739 totalExercise: $35.50Exp: 2026-12-20→ Common Stock (2,739 underlying) - Award
Stock Option (Right to Buy)
2016-12-20+6,000→ 6,000 totalExercise: $35.50Exp: 2026-12-20→ Common Stock (6,000 underlying) - Award
Common Stock
2016-12-20+1,026→ 1,026 total
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Common Stock of AMAG Pharmaceuticals, Inc. (the "Issuer"). These shares of Common Stock are issuable pursuant to a grant of restricted stock units pursuant to the Issuer's Third Amended & Restated 2007 Equity Incentive Plan, as amended (the "Plan") that will vest in five equal monthly installments commencing on January 1, 2017; however, delivery of the shares is deferred until the earlier of (a) one year from the date of grant and (b) the date of the director's separation from service to the Issuer.
- [F2]Not applicable.
- [F3]Grant of stock option pursuant to the Plan. This option will vest and become exercisable in twenty-four equal monthly installments over two years from the date of grant.
- [F4]Grant of stock option pursuant to the Plan. This option will vest and become exercisable in five equal monthly installments commencing January 1, 2017.
Documents
Issuer
AMAG PHARMACEUTICALS INC.
CIK 0000792977
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000792977
Filing Metadata
- Form type
- 4
- Filed
- Dec 21, 7:00 PM ET
- Accepted
- Dec 22, 5:06 PM ET
- Size
- 9.5 KB